Skip to content

DR. INGE SCHOEFS: what changed

BE 0842.114.903NACE 86.210, General medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€74,349
2024 · €61,722+€12,627
Equity
€328,406
2024 · €300,368+€28,039
Cash
€333,418
2024 · €256,019+€77,399
Balance sheet total
€363,927
2024 · €333,104+€30,823

Largest movements

2024 to 2025
Assets
  • Cash +€77,399

    up €77,399 (+30.2%), from €256,019 to €333,418

    mainly Net result for the year (+€74,349) and Current investments (+€50,000)

  • Current investments -€50,000

    down €50,000 (-100%), from €50,000 to €0

Equity and liabilities
  • Reserves +€40,039

    up €40,039 (+13.9%), from €287,968 to €328,006

  • Contributions -€12,000

    down €12,000 (-96.8%), from €12,400 to €400

Income statement
  • Gross operating margin +€12,639

    up €12,639 (+14.7%), from €85,862 to €98,501

  • Financial income -€1,905

    down €1,905 (-39.5%), from €4,824 to €2,920

  • Depreciation -€1,070

    down €1,070 (-32.0%), from €3,340 to €2,270

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €61,722
Gross operating margin +€12,639
Depreciation +€1,070
Other operating charges -€129
Financial income -€1,905
Financial charges +€139
Taxes +€812
Result 2025 €74,349
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€77,564
Investment +€46,145
Financing -€46,310
Cash 2024 €256,019
Net result for the year +€74,349
Depreciation +€2,270
Receivables within one year -€1,493
Deferred charges and accrued income -€345
Trade debts +€555
Tax, wage and social debts +€905
Other debts +€1,324
Investment in fixed assets (net) -€3,855
Current investments +€50,000
Contributions, distributions and other -€46,310
Cash 2025 €333,418
brings cash intakes cash out
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €333,104 €363,927 +€30,823 +9.3%
Fixed assets 21/28 €5,357 €6,942 +€1,585 +29.6%
Tangible fixed assets 22/27 €5,357 €6,942 +€1,585 +29.6%
Plant, machinery and equipment 23 €805 €341 -€464 -57.7%
Furniture and vehicles 24 €4,552 €6,601 +€2,050 +45.0%
Current assets 29/58 €327,747 €356,985 +€29,238 +8.9%
Amounts receivable after more than one year 29 €10,000 €10,000 = 0.0%
Other amounts receivable 291 €10,000 €10,000 = 0.0%
Amounts receivable within one year 40/41 €1,811 €3,304 +€1,493 +82.5%
Trade receivables 40 - €2,500 +€2,500
Other amounts receivable 41 €1,811 €804 -€1,007 -55.6%
Current investments 50/53 €50,000 €0 -€50,000 -100%
Cash at bank and in hand 54/58 €256,019 €333,418 +€77,399 +30.2%
Deferred charges and accrued income 490/1 €9,917 €10,262 +€345 +3.5%
Total equity and liabilities 10/49 €333,104 €363,927 +€30,823 +9.3%
Equity 10/15 €300,368 €328,406 +€28,039 +9.3%
Contributions 10/11 €12,400 €400 -€12,000 -96.8%
Reserves 13 €287,968 €328,006 +€40,039 +13.9%
Distributable reserves 133 €287,968 €328,006 +€40,039 +13.9%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €32,736 €35,520 +€2,784 +8.5%
Amounts payable within one year 42/48 €32,736 €35,520 +€2,784 +8.5%
Current portion of amounts payable after more than one year 42 €0 - =
Trade debts 44 €1,674 €2,229 +€555 +33.2%
Suppliers 440/4 €1,674 €2,229 +€555 +33.2%
Taxes, remuneration and social security 45 €1,553 €2,459 +€905 +58.3%
Taxes 450/3 €1,553 €2,459 +€905 +58.3%
Other amounts payable 47/48 €29,509 €30,832 +€1,324 +4.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €3,340 €2,270 -€1,070 -32.0%
Other operating charges 640/8 €508 €638 +€129 +25.4%
Gross operating margin 9900 €85,862 €98,501 +€12,639 +14.7%
Operating profit (loss) 9901 €82,013 €95,594 +€13,581 +16.6%
Financial income 75/76B €4,824 €2,920 -€1,905 -39.5%
Recurring financial income 75 €4,824 €2,920 -€1,905 -39.5%
Financial charges 65/66B €743 €604 -€139 -18.8%
Recurring financial charges 65 €743 €604 -€139 -18.8%
Profit (loss) for the period before taxes 9903 €86,094 €97,910 +€11,816 +13.7%
Income taxes 67/77 €24,372 €23,561 -€812 -3.3%
Profit (loss) for the period 9904 €61,722 €74,349 +€12,627 +20.5%
Profit (loss) for the period to be appropriated 9905 €61,722 €74,349 +€12,627 +20.5%

Value

latest balance sheet 30-06-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€407,875 to €505,343

Midpoint €448,487 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €328,406
Capitalised earnings €487,343 to €682,280
Indication €407,875 to €505,343

Adjusted equity

balance sheet 30-06-2025
Equity (10/15)
€328,406
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€328,406

Capitalised earnings

net result for the year (9904)
2025
€74,349
2024
€61,722
2023
€68,613
2022
€52,652
2021
€70,671
Average result
€68,228
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€487,343 / €568,567 / €682,280

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 June 2024 and 30 June 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 9 November 2026 via checked.be.